Lecithin vesicles for topical delivery of diclofenac
Lecithin vesicles for topical delivery of diclofenac
复制标题
DOI:
10.1016/s0939-6411(03)00143-7
复制
发表时间:
2003-11-01
影响因子:
4.9
通讯作者:
Jasti, BR
中科院分区:
文献类型:
--
作者:
Boinpally, RR;Zhou, SL;Jasti, BR
Skin penetration of topically applied diclofenac is important for the treatment of rheumatic diseases and actinic keratoses. We have studied the permeation of diclofenac across human cadaver epidermis in-vitro from four lecithin vesicle formulations and a few marketed semi-solid preparations. The lecithin vesicle formulations were prepared by dissolving the lipid contents (lecithin and sodium cholate) in a 1:1 mixture of methanol-chloroform, evaporating the solvents under vacuum, and hydrating the lipid layer with the drug solution in water or 10% ethanol. The vesicles were sonicated for 5 min to reduce the vesicle size and their size and Zeta potential were characterized. The cumulative amount and maximum flux of diclofenac was 69.7 +/- 40.3 mug and 4.77 +/- 3.16 mug/h cm(2) from lecithin vesicles containing sodium cholate and 10% ethanol, and is the highest of all formulations studied. The cumulative amount and mean maximum flux obtained from other formulations were in the range of 2.46 +/- 1.98-29.9 +/- 10.1 mug and 0.53 +/- 0.46-3.61 +/- 0.86 mug/h cm(2). Based on the results, lecithin vesicles of diclofenac appear to be advantageous for the topical delivery of diclofenac. (C) 2003 Elsevier B.V. All rights reserved.